ELIZABETH E REED Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ELIZABETH E REED.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ELIZABETH E REED. ELIZABETH E REED is SVP, GC & Corporate Secretary in Retrophin, Inc. ($RTRX).
Latest Insider Trading Transactions of ELIZABETH E REED
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 4,500 | 0 | 42,205 | 37.7 K to 42.2 K (+11.93 %) |
Feb 05 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 4,500 | 0 | 42,205 | 37.7 K to 42.2 K (+11.93 %) |
Feb 03 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 28.91 | 675 | 19,514 | 37,705 | 38.4 K to 37.7 K (-1.76 %) |
Feb 03 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 28.91 | 2,500 | 72,275 | 38,380 | 40.9 K to 38.4 K (-6.12 %) |
Feb 02 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 30.75 | 675 | 20,756 | 40,880 | 41.6 K to 40.9 K (-1.62 %) |
Feb 02 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 30.75 | 2,500 | 76,875 | 41,555 | 44.1 K to 41.6 K (-5.67 %) |
Feb 02 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 5,000 | 0 | 44,055 | 39.1 K to 44.1 K (+12.80 %) |
Jan 25 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 26.88 | 57,500 | 1,545,600 | 57,500 | |
Jan 25 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 15,000 | 0 | 39,055 | 24.1 K to 39.1 K (+62.36 %) |
Jan 07 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 27.01 | 688 | 18,583 | 24,055 | 24.7 K to 24.1 K (-2.78 %) |
Jan 07 2021 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 26.65 | 688 | 18,335 | 24,743 | 25.4 K to 24.7 K (-2.71 %) |
Nov 17 2020 | RTRX | Travere Therapeuti ... | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 23.98 | 2,500 | 59,950 | 25,431 | 27.9 K to 25.4 K (-8.95 %) |
Nov 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 23.62 | 2,500 | 59,046 | 27,931 | 30.4 K to 27.9 K (-8.22 %) |
Nov 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 5,000 | 0 | 30,431 | 25.4 K to 30.4 K (+19.66 %) |
Sep 23 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 18.48 | 1,500 | 27,720 | 25,431 | 26.9 K to 25.4 K (-5.57 %) |
Sep 22 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 18.59 | 1,500 | 27,885 | 26,931 | 28.4 K to 26.9 K (-5.28 %) |
Sep 22 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 3,000 | 0 | 28,431 | 25.4 K to 28.4 K (+11.80 %) |
Sep 22 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 18.59 | 1,500 | 27,885 | 26,931 | 28.4 K to 26.9 K (-5.28 %) |
Sep 22 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 3,000 | 0 | 28,431 | 25.4 K to 28.4 K (+11.80 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 16.98 | 527 | 8,951 | 25,431 | 26 K to 25.4 K (-2.03 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.16 | 525 | 9,009 | 25,958 | 26.5 K to 26 K (-1.98 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 14.95 | 525 | 7,849 | 26,483 | 27 K to 26.5 K (-1.94 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 16.98 | 527 | 8,951 | 25,431 | 26 K to 25.4 K (-2.03 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.16 | 525 | 9,009 | 25,958 | 26.5 K to 26 K (-1.98 %) |
May 13 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 14.95 | 525 | 7,849 | 26,483 | 27 K to 26.5 K (-1.94 %) |
Mar 12 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 15.02 | 3,500 | 52,570 | 27,008 | 30.5 K to 27 K (-11.47 %) |
Mar 09 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 3,500 | 0 | 30,508 | 27 K to 30.5 K (+12.96 %) |
Jan 31 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
Jan 31 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 9,000 | 0 | 27,008 | 18 K to 27 K (+49.98 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 15.14 | 750 | 11,355 | 18,008 | 18.8 K to 18 K (-4.00 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 13.94 | 750 | 10,455 | 18,758 | 19.5 K to 18.8 K (-3.84 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 15.14 | 750 | 11,355 | 18,008 | 18.8 K to 18 K (-4.00 %) |
Jan 08 2020 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 13.94 | 750 | 10,455 | 18,758 | 19.5 K to 18.8 K (-3.84 %) |
May 16 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.71 | 525 | 9,298 | 19,508 | 20 K to 19.5 K (-2.62 %) |
May 16 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.75 | 525 | 9,319 | 20,033 | 20.6 K to 20 K (-2.55 %) |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 6,000 | 0 | 20,558 | 14.6 K to 20.6 K (+41.21 %) |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 6,000 | 0 | 20,558 | 14.6 K to 20.6 K (+41.21 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 21.50 | 884 | 19,006 | 14,558 | 15.4 K to 14.6 K (-5.72 %) |
Feb 13 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 21.38 | 885 | 18,921 | 15,442 | 16.3 K to 15.4 K (-5.42 %) |
Jan 09 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 23.82 | 750 | 17,865 | 16,327 | 17.1 K to 16.3 K (-4.39 %) |
Jan 09 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 24.09 | 750 | 18,068 | 17,077 | 17.8 K to 17.1 K (-4.21 %) |
Nov 16 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 24.81 | 100 | 2,481 | 17,827 | 17.9 K to 17.8 K (-0.56 %) |
Nov 16 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 24.77 | 100 | 2,477 | 17,927 | 18 K to 17.9 K (-0.55 %) |
Nov 16 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 24.29 | 2,300 | 55,858 | 18,027 | 20.3 K to 18 K (-11.31 %) |
Nov 16 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 24.57 | 300 | 7,371 | 20,327 | 20.6 K to 20.3 K (-1.45 %) |
Nov 16 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 23.62 | 2,200 | 51,959 | 20,627 | 22.8 K to 20.6 K (-9.64 %) |
May 14 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
May 14 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 25.25 | 42,000 | 1,060,500 | 42,000 | |
May 14 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 7,000 | 0 | 17,827 | 10.8 K to 17.8 K (+64.65 %) |
Feb 12 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 1,769 | 0 | 10,827 | 9.1 K to 10.8 K (+19.53 %) |
Jan 08 2018 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 24.04 | 942 | 22,646 | 9,058 | 10 K to 9.1 K (-9.42 %) |
Jan 06 2017 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 19.08 | 50,000 | 954,000 | 50,000 | |
Jan 06 2017 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1